Atlas Trials

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer

Clinical trial NCT01082068 · COMPLETED

Trial details

NCT number
NCT01082068
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-06-01
Primary completion
2013-04-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.